Cointime

ExcepGen

company

About

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

  • San Francisco,California,United States
  • 1 - 10

Highlights

Total Funding Amount
$9.15M
Funding Rounds
2
Investors
3
Employee Profiles
2

Details

Last Funding Type
Seed
Last Funding Money Raised
$9M
Industries
Biopharma,Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
ExcepGen Inc.

ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$9.15M
ExcepGen has raised a total of $9.15M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2020 Seed $9M 1 — — Detail
Mar 18, 2019 Seed $150K 2 Y Combinator — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
ExcepGen is funded by 3 investors. Y Combinator and SVA are the most recent investors.
Investor Name Lead Investor Funding Round
Y Combinator Yes Seed
SVA — Seed
Pi Campus — Seed

Employee Profiles

Number of Employee Profiles
2
ExcepGen has 2 current employee profiles, including Executive Barbara Mertins
Barbara Mertins
Executive
Thomas Folliard
Executive
Cointime
Content
Company